1. Home
  2. NVAX vs WRBY Comparison

NVAX vs WRBY Comparison

Compare NVAX & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • WRBY
  • Stock Information
  • Founded
  • NVAX 1987
  • WRBY 2010
  • Country
  • NVAX United States
  • WRBY United States
  • Employees
  • NVAX N/A
  • WRBY N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • WRBY Ophthalmic Goods
  • Sector
  • NVAX Health Care
  • WRBY Health Care
  • Exchange
  • NVAX Nasdaq
  • WRBY Nasdaq
  • Market Cap
  • NVAX 2.0B
  • WRBY 1.9B
  • IPO Year
  • NVAX 1995
  • WRBY 2021
  • Fundamental
  • Price
  • NVAX $9.76
  • WRBY $17.23
  • Analyst Decision
  • NVAX Buy
  • WRBY Buy
  • Analyst Count
  • NVAX 6
  • WRBY 8
  • Target Price
  • NVAX $17.83
  • WRBY $16.88
  • AVG Volume (30 Days)
  • NVAX 7.2M
  • WRBY 1.4M
  • Earning Date
  • NVAX 11-07-2024
  • WRBY 11-07-2024
  • Dividend Yield
  • NVAX N/A
  • WRBY N/A
  • EPS Growth
  • NVAX N/A
  • WRBY N/A
  • EPS
  • NVAX N/A
  • WRBY N/A
  • Revenue
  • NVAX $987,667,000.00
  • WRBY $719,929,000.00
  • Revenue This Year
  • NVAX N/A
  • WRBY $15.94
  • Revenue Next Year
  • NVAX N/A
  • WRBY $13.07
  • P/E Ratio
  • NVAX N/A
  • WRBY N/A
  • Revenue Growth
  • NVAX N/A
  • WRBY 13.67
  • 52 Week Low
  • NVAX $3.53
  • WRBY $9.83
  • 52 Week High
  • NVAX $23.86
  • WRBY $18.37
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 36.20
  • WRBY 57.79
  • Support Level
  • NVAX $9.52
  • WRBY $16.71
  • Resistance Level
  • NVAX $10.63
  • WRBY $17.86
  • Average True Range (ATR)
  • NVAX 0.57
  • WRBY 0.66
  • MACD
  • NVAX -0.12
  • WRBY 0.01
  • Stochastic Oscillator
  • NVAX 9.97
  • WRBY 62.77

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About WRBY Warby Parker Inc.

Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Share on Social Networks: